安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Products - 13
Our portfolio of patented novel anti-inflammatory peptides have application for the treatment of a variety of inflammatory diseases These anti-inflammatory therapeutics target individual intracellular signaling pathways of the Toll-Like Receptor (TLR) pathway
- TLR4 Inhibitor Peptide Set - Novus Biologicals
A novel model system is shown in Image 1 where TLR4 inhibitor peptide, but not CP7, inhibited TLR4 activation in Mal-deficient immortalized mouse bone marrow-derived macrophages (iBMDMs) In these iBMDMs, the inhibitor targets TLR4-TRAM, but not TLR-Mal, interactions as Mal is not expressed
- TLR Inhibitor : molecules known to block TLR (Toll-like receptor . . .
TLR signaling inhibitors and TLR antagonists InvivoGen provides a large collection of inhibitors to target Toll-Like Receptor (TLR) mediated signaling pathways Depending on your needs, you may choose from: - TLR signaling inhibitors - TLR antagonists - TLR neutralizing antibodies
- Human TLR1 Synthetic Peptide (PEP-0297) - Thermo Fisher Scientific
Invitrogen Human TLR1 Peptide, Catalog # PEP-0297 Tested in Blocking Assay (BLOCK) and Control (Ctrl) applications Supplied as 50 µg purified peptide (200 µg mL)
- Toll-like Receptor (TLR) Inhibitors - Bio-Techne
The TLRs and their downstream signaling pathways can be studied with cell-permeable inhibitor peptides Inhibitor peptides block signaling events through decoy action: a realistic replica used as a lure or bait Each peptide employs a specific decoy mechanism that blocks the propagation of downstream signaling pathways
- Toll-like Receptor Agonists: Products - R D Systems
View our 8 Toll-like Receptor Agonists products for your research including Toll-like Receptor Agonists Small Molecules and Toll-like Receptor Agonists Peptides
- Commercial products at PolyPeptide
PolyPeptide produces one third of the commercially approved peptides in the world Our long standing experience in regulatory filing for commercially approved products, assures our clients fluidity in their interactions with domestic and foreign agencies
- New eye drops successfully treat age-related macular degeneration
By leveraging their extensive peptide library, they identified candidates capable of modulating TLR signaling These peptides were formulated into eye drops, a preferred method of drug delivery in ophthalmology, offering a less invasive alternative to injections
|
|
|